1	5 patient on immunosuppression e.g. corticosteroid mycophenolate mofetil azathioprine cyclophosphamide be eligible if the dose of the immunosuppressive drug have be stable for at least 3 month prior to enrollment and their hematologic parameter do not meet the exclusion criterion 1 a outline below|immunosuppressive[134,151]|||||||3 month[185,192]|||5748|5748|immunosuppressive
1	5 patient on immunosuppression e.g. corticosteroid mycophenolate mofetil azathioprine cyclophosphamide be eligible if the dose of the immunosuppressive drug have be stable for at least 3 month prior to enrollment and their hematologic parameter do not meet the exclusion criterion 1 a outline below|cyclophosphamide[86,102]|||||||||C0010583|3002|3002|cyclophosphamide
1	5 patient on immunosuppression e.g. corticosteroid mycophenolate mofetil azathioprine cyclophosphamide be eligible if the dose of the immunosuppressive drug have be stable for at least 3 month prior to enrollment and their hematologic parameter do not meet the exclusion criterion 1 a outline below|azathioprine[73,85]|||||||||C0004482|1256|1256|azathioprine
1	5 patient on immunosuppression e.g. corticosteroid mycophenolate mofetil azathioprine cyclophosphamide be eligible if the dose of the immunosuppressive drug have be stable for at least 3 month prior to enrollment and their hematologic parameter do not meet the exclusion criterion 1 a outline below|mycophenolate mofetil[51,72]|||||||||C0209368|68149|68149|mycophenolate mofetil
1	5 patient on immunosuppression e.g. corticosteroid mycophenolate mofetil azathioprine cyclophosphamide be eligible if the dose of the immunosuppressive drug have be stable for at least 3 month prior to enrollment and their hematologic parameter do not meet the exclusion criterion 1 a outline below|corticosteroid[36,50]||||||||||354|354|corticosteroid
